ARTICLE | Distillery Therapeutics
PROK2-mediated suppression of ferroptosis as a target for traumatic brain injury
August 27, 2021 8:20 PM UTC
DISEASE CATEGORY: Inflammation
INDICATION: Shock/trauma...
BCIQ Company Profiles
BCIQ Target Profiles
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
DISEASE CATEGORY: Inflammation
INDICATION: Shock/trauma...
BCIQ Company Profiles
BCIQ Target Profiles